The largest database of trusted experimental protocols

303 protocols using carrageenan

1

Carrageenan-Induced Acute Muscle Damage

Check if the same lab product or an alternative is used in the 5 most similar protocols
Male Sprague Dawley rats were obtained from and housed in our institution’s laboratory animal center. They were housed individually in a room with a 12/12-h light/dark cycle and with central air conditioning (25 °C, 70% humidity). The animal care and experimental protocols were in accordance with institutional guidelines, which were approved by the National Cheng Kung University Animal Center (Approval number: 105035). For inducing acute muscular damage in rats, carrageenan, purchased from Sigma (Cat.#C1013, St Louis, MO, USA), was injected in the amount of 100 μL of 3% carrageenan into rats’ left gastrocnemius muscle under isoflurane (3%) anesthesia, as published previously [23 (link)].
+ Open protocol
+ Expand
2

Carrageenan-Induced Pain Memory Model

Check if the same lab product or an alternative is used in the 5 most similar protocols
In our previous study, the pain memory model was induced by two injections of carrageenan [2 (link), 3 (link)]. The first carrageenan injection was placed into the left hind paw plantar surface via the subcutaneous injection of 0.1 mL of 2% carrageenan (Sigma-Aldrich, St. Louis, MO, USA) to induce acute inflammatory pain. After a 14-day recovery period, when the right hind paw was also injected with the same carrageenan, the pain threshold of the recovered left hind paw dropped again. This shows that the pain memory model was successfully prepared. The basic experimental procedure is shown in Figure 1.
+ Open protocol
+ Expand
3

Carrageenan-Induced Pain Memory Retrieval Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
As described previously [21 (link)], the pain memory model induced by two injections of carrageenan was selected to complete the study. The first carrageenan injection was placed into the left hind paw plantar surface via the subcutaneous injection of 0.1 mL of 2% carrageenan (Sigma Chemical Co, St. Louis, MO, USA) to induce acute inflammatory pain. After a 14-day recovery period, the pain value of the left hind paw was recovered. Then the second carrageenan injection was placed into the right hind paw to induce another pain. At this time, the left hind paw, which did not receive the second injection of carrageenan, appeared to exhibit nociceptive hyperalgesia. In the present study, the hyperalgesia of the left hind paw was regarded as the retrieval of pain memory [21 (link), 22 (link)].
+ Open protocol
+ Expand
4

Carrageenan-Induced Paw Edema Model

Check if the same lab product or an alternative is used in the 5 most similar protocols
Rats in the test
group showed edema in their right hind paws after being injected with
0.2 mL of 1% (w/v) carrageenan (Sigma-Aldrich, St. Louis, USA), with
a volume of 0.2 mL, on the plantar side of the right hind paw.75 (link) Before the carrageenan injection, the paw diameter
was measured. After the carrageenan injection, the paw diameter was
measured each hour up to five times, then after 24 and 48 h. The rats
were split into three groups, where each group included six members.
For the first group (control group), normal saline was administered
(3 mL/kg body weight), whereas for the second group, the usual anti-inflammatory
medication was used; diclofenac (Troge, Germany) (100 mg/kg body weight
p.o.) was given. The NPs (400 mg/kg body weight po) were given to
the third group. One hour before administering carrageenan, the animals
were pretreated. Using this method, we estimated the percentage inhibition
of edema
+ Open protocol
+ Expand
5

Carrageenan-Induced Inflammation Model

Check if the same lab product or an alternative is used in the 5 most similar protocols
We obtained carrageenan (catalog: C1013, Predominantly κ and lesser amounts of λ carrageenan), minocycline (catalog: M9511), U0126 (catalog: U120), L-2-Aminoadipate acid (L-AA; catalog: A7275), and carbenoxolone (CBX; catalog: C4790) from Sigma-Aldrich, SB 225002 (catalog: 182498-32-4) from Tocris, and CXCL1 neutralizing antibody (catalog: A00533) from Boster.
+ Open protocol
+ Expand
6

Carrageenan-Induced Inflammatory Pain Model

Check if the same lab product or an alternative is used in the 5 most similar protocols
Peripheral inflammation of the hind paw was induced 24 h before the i.t. treatment or spinal cord slice preparation. Under brief isoflurane (3%, Forane®, Abbott, Barcelona, Spain), an anesthesia intraplantar injection of 20 μL of carrageenan (3%, Sigma-Aldrich, St. Louis, MO, USA) dissolved in a physiological solution was made in both hind paws of 20–22-day-old (40–50 g) rats before spinal cord slices preparation for electrophysiological experiments and 150 μL of carrageenan (3%) into the hind paw of 8–10-week-old (250–350 g) rats used for behavioral testing. The animals were left to recover in their home cages. The inflammation with associated thermal hyperalgesia was fully developed 24 h after carrageenan injection.
+ Open protocol
+ Expand
7

Analgesic Compounds: Purification and Preparation

Check if the same lab product or an alternative is used in the 5 most similar protocols
The following drugs and chemicals were used: δ-CNTX-Pn1a was purified by a combination of preparative reverse phase HPLC (RP-HPLC), ion exchange HPLC and analytical reverse phase HPLC as previously described [52 (link)]. µ-Conotoxin MVIIA was purchased from Latoxan (Valence, France). Carrageenan (Sigma, St Louis, MO, USA), Prostaglandin E2 (Enzo Life Sciences, Farmingdale, NY, USA), AM251 (N-(piperidin-1-yl)-5-(4-iodophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide; Tocris, Pittsburg, PA, USA), AM630 (6-iodo-2-methyl-1-[2-(4-morpholinyl)ethyl]-1H-indol-3-yl(4-ethoxyphenyl) methanone Tocris, Pittsburgh, PA, USA), Naloxone (Sigma, St. Louis, MO, USA), Clocinnamox (Tocris, Pittsburgh, PA, USA), Naltrindole (Tocris, Pittsburgh, PA, USA), Nor-BNI (Nor-Binaltorphimine dihydrochloride; Sigma, St. Louis, MO, USA) were dissolved as follows: PGE2 (2% ethanol in saline); AM251 and AM630 (12% DMSO in saline); Carrageenan, δ-CNTX-Pn1a, µ-Conotoxin MVIIA (MVIIA), Naloxone, Clocinnamox, Naltrindole and Nor-BNI (saline).
+ Open protocol
+ Expand
8

Carrageenan and Chitosan Coatings for Chicken

Check if the same lab product or an alternative is used in the 5 most similar protocols
A 0.2% (w/v) carrageenan (Sigma-Aldrich, St. Louis, MO) coating was prepared by adding 8 g of carrageenan to 4 L of distilled water, and the suspension was mixed on a stir plate for 24 h at room temperature. The 0.2% (w/v) chitosan (Sigma-Aldrich, St. Louis, MO) coating was prepared similarly in 4 L of 1% lactic acid (Fisher Scientific, Fair Lawn, NJ). The coatings were placed in two separate glass containers for immersing the chicken breast samples. An AITC (≥95% purity; Koptec, King of Prussia, PA) working stock solution (1:5 dilution) was prepared by adding 2 mL of AITC to 8 mL of 90-proof ethanol (Fisher Scientific, Fair Lawn, NJ). An additional dilution of this stock was prepared by adding 1 mL of the 1:5 dilution to 9 mL of 90-proof ethanol to give a 1:50 working stock solution. The working stocks were then used to prepare the AITC treatment solutions on the day of the experiment by separately adding 1 mL of each working stock to 999 mL of sterile distilled water to obtain 2 solutions at final AITC concentrations of 20 and 200 ppm.
+ Open protocol
+ Expand
9

Carrageenan-Induced Muscle Inflammation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Thirty rats were divided into five groups. In the normal (N) group, rats received 100 μL of saline by gastrocnemius muscle injection into the left limbs and 500 μL of saline by intraperitoneal (i.p.) injection; in the control (C) group, rats received 100 μL of 3% carrageenan (Sigma-Aldrich, St Louis, MO, USA) by gastrocnemius muscle injection into the left limbs and 500 μL of saline by i.p. injection; and in the CT30, 100, and 300 groups, rats received 100 μL of 3% carrageenan by gastrocnemius muscle injection into the left limbs and 500 μL of triptolide (Cat.#T3652, Sigma-Aldrich, St Louis, MO, 30, 100, and 300 mg/kg) by i.p. injection. Six hours after the above treatments, a pan behavior test was performed in each rat. After this, rats were euthanized, and their serum and muscle tissue samples were collected for further analyses.
+ Open protocol
+ Expand
10

Analgesic and Anti-inflammatory Evaluation of Lawsone Extracts

Check if the same lab product or an alternative is used in the 5 most similar protocols
Lawsone, carrageenan, chloroform, methanol, benzene, ethyl acetate, ammonium hydroxide, and anhydrous sodium carbonate were obtained from Aldrich (Sigma -Aldrich, Germany).
Animals A total of 120 healthy adult mice (weighing about 25±5 g) were obtained from the laboratory animal house, College of Science, University of Thi-Qar. The study was carried out in the College of Medicine, Thi-Qar university from January to August 2021. Animals were housed in polyacrylic cages and kept under standard laboratory conditions (natural light/dark cycle, RT 22±3°C). Animals were fed a dry rat pellet diet, and tap water was provided ad libitum. Thi-Qar university animal ethics committee approved the experimental protocol. Sixty mice were used to determine LD 50 and 30 mice for the anti-inflammatory test and 30 for an analgesic test. The animal ethics committee supervised by the Institute for the Prevention of Cruelty to Animals and the Research Council reviewed and approved the current study, and Thi-Qar university's animal ethics committee approved the experimental protocol (456/1Q) 24.11.2020. The European Council Directive recommendations (2010/63/EU) on September 22, 2010, amended by Regulation (EU) 2019/1010, on standards to protect animals used experimentally were also followed.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!